Works by Geng, Chuanying
Results: 24
The Prognostic Role of Prothrombin Time and Activated Partial Thromboplastin Time in Patients with Newly Diagnosed Multiple Myeloma.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/6689457
- By:
- Publication type:
- Article
A Report of 134 Newly Diagnosed Multiple Myeloma Patients with Renal Impairment.
- Published in:
- Acta Haematologica, 2016, v. 135, n. 3, p. 140, doi. 10.1159/000440935
- By:
- Publication type:
- Article
Clinical characteristics of a group of patients with multiple myeloma who had two different λ light chains by immunofixation electrophoresis: A retrospective study from a single center.
- Published in:
- Experimental & Therapeutic Medicine, 2015, v. 9, n. 5, p. 1895, doi. 10.3892/etm.2015.2352
- By:
- Publication type:
- Article
Multiple myeloma with extramedullary plasmacytoma invading the skin and eyeballs following autologous stem cell transplantation: A case report.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Target and resistance-related proteins of recombinant mutant human tumor necrosis factor-related apoptosis-inducing ligand on myeloma cell lines.
- Published in:
- Biomedical Reports, 2016, v. 4, n. 6, p. 723, doi. 10.3892/br.2016.650
- By:
- Publication type:
- Article
Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 4, p. 666, doi. 10.3390/jpm13040666
- By:
- Publication type:
- Article
Prognostic value of t(4;14) translocation in newly diagnosed multiple myeloma patients in novel agent era.
- Published in:
- Hematology, 2023, v. 28, n. 1, p. 1, doi. 10.1080/16078454.2022.2161222
- By:
- Publication type:
- Article
Comparable outcome of stem cell transplant versus bortezomib-based consolidation in myeloma patients after major response to induction.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Echocardiography‐defined pulmonary hypertension is an adverse prognostic factor for newly diagnosed multiple myeloma patients.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 22, p. 4182, doi. 10.1002/cam4.4770
- By:
- Publication type:
- Article
Low Barthel index score is a poor prognostic factor for newly diagnosed multiple myeloma patients.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 6, p. 2593, doi. 10.1007/s10238-023-01002-7
- By:
- Publication type:
- Article
CD20 expression: A risk stratification factor for newly diagnosed multiple myeloma with t(11;14).
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1061438
- By:
- Publication type:
- Article
Paired comparisons of venetoclax concentration in cerebrospinal fluid, bone marrow, and plasma in acute leukemia patients.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 9, p. 1, doi. 10.1111/cts.70006
- By:
- Publication type:
- Article
The effects of nutritional support on cellular immunity of the patient with multiple myeloma undergoing chemotherapy.
- Published in:
- Panminerva Medica, 2023, v. 65, n. 2, p. 263, doi. 10.23736/S0031-0808.19.03785-6
- By:
- Publication type:
- Article
Cyclopamine sensitizes multiple myeloma cells to circularly permuted TRAIL-induced apoptosis.
- Published in:
- Oncology Letters, 2021, v. 21, n. 4, p. N.PAG, doi. 10.3892/ol.2021.12556
- By:
- Publication type:
- Article
Arsenic trioxide potentiates sensitivity of multiple myeloma cells to lenalidomide by upregulating cereblon expression levels.
- Published in:
- Oncology Letters, 2017, v. 14, n. 3, p. 3243, doi. 10.3892/ol.2017.6502
- By:
- Publication type:
- Article
Retrospective analysis of genetic abnormalities and survival in 131 patients with multiple myeloma.
- Published in:
- Oncology Letters, 2015, v. 9, n. 2, p. 930, doi. 10.3892/ol.2014.2750
- By:
- Publication type:
- Article
A multicenter, open-label phase II study of recombinant CPT (Circularly Permuted TRAIL) plus thalidomide in patients with relapsed and refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 11, p. 1037, doi. 10.1002/ajh.23822
- By:
- Publication type:
- Article
Incidence and Risk Factors of Osteonecrosis of Femoral Head in Multiple Myeloma Patients Undergoing Dexamethasone-Based Regimens.
- Published in:
- BioMed Research International, 2020, p. 1, doi. 10.1155/2020/7126982
- By:
- Publication type:
- Article
At least two high-risk cytogenetic abnormalities indicate the inferior outcomes for newly diagnosed multiple myeloma patients: a real-world study in China.
- Published in:
- Leukemia & Lymphoma, 2021, v. 62, n. 12, p. 2992, doi. 10.1080/10428194.2021.1948032
- By:
- Publication type:
- Article
Deep and partial immunoparesis is a poor prognostic factor for newly diagnosed multiple myeloma patients.
- Published in:
- Leukemia & Lymphoma, 2021, v. 62, n. 4, p. 883, doi. 10.1080/10428194.2020.1855345
- By:
- Publication type:
- Article
Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study.
- Published in:
- Turkish Journal of Hematology, 2020, v. 37, n. 2, p. 91, doi. 10.4274/tjh.galenos.2019.2019.0254
- By:
- Publication type:
- Article
Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10382-0
- By:
- Publication type:
- Article
Triplet RVd Induction for Transplant-Eligible Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Chromosome 1q21 Aberrations Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients.
- Published in:
- Journal of Clinical Laboratory Analysis, 2024, v. 38, p. 1, doi. 10.1002/jcla.25072
- By:
- Publication type:
- Article